Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
IMS: Review of Chinese Retail Pharmacy OTC Drug Sales in 2015
The Chinese OTC drug sales reached CNY 179 billion in 2015, up 8.3% year on year, according to IMS Health. Among the total, 60% were contributed by retail pharmacies, inc... (5/22/2016)
   
China's Drugs Watchdog Struggles as Senior Staff Lured Away By Industry (5/23/2016)
Strategic Domains In The U.S.-China Life Science Sector (5/23/2016)
13FYP Paints a Gloomy Picture for Healthcare MNCs (5/20/2016)
Foreign Firms Need New Strategies For China's 'New Normal' (5/16/2016)
Scandals Keep Blindsiding China's Food And Drug Regulator, So What's the Missing Ingredient? (5/16/2016)
Gov't Forces Big Pharma to Swallow A Bitter Pill (5/14/2016)
China's Regulators Come Knocking Again At Pharma's Door (5/14/2016)
Repercussions of Irrational Cost Containment Surface as Premier Calls for More Drug Price Cut (5/6/2016)
China's Life Science Innovative Development Policies (5/3/2016)
China's Coming Crackdown on Healthcare Corruption (4/29/2016)
In China's Tougher Drug Market, Minnows Open Back Door for 'Big Pharma' (4/29/2016)
Kendall Squared - Chinese Biopharma Companies Set down Roots in Boston Area (4/14/2016)
Compliance in China: Ongoing Regulatory and Operational Challenges (4/8/2016)
Advice for Biopharmas in China? Mind the Gap (4/8/2016)
'Chindia' Drug Substance Market Not To Be Discounted (4/7/2016)
Eisai's Breast Cancer Drug Positive in C...  (5/23/2016)
CPA: Review of Chinese Hospital Drug Mar...  (5/23/2016)
Data Snapshot - Drug Consumption of Leve...  (5/23/2016)
Data Snapshot: Chinese Insulin Market in...  (5/22/2016)
IMS: Review of Chinese Retail Pharmacy O...  (5/22/2016)
IMS: New Market Trends in the Changing C...  (5/22/2016)
New Study: China, India Face Huge Mental...  (5/20/2016)
NHFPC Announces First Round Outcome of N...  (5/20/2016)
CFDA Issues Guidelines for Exemption of ...  (5/20/2016)
CFDA Issues the Procedures for Reference...  (5/20/2016)
Novartis Splits Pharmaceuticals Division...  (5/20/2016)
China Leads Global Pharma Innovation? By...  (5/20/2016)
NT Pharma, Novartis Enter $145M Deal for...  (5/19/2016)
Recent Executive Movements  (5/19/2016)
IMS: Review of Chinese Hospital Drug Mar...  (5/19/2016)
Novartis Splits Pharmaceuticals Division Into Two Busine...
IMS Health Holdings and Quintiles to Combine
Pfizer Abandons Plans to Take Over Allergan Citing New U...
Top 15 Pharma MNCs Experienced Stagnant Performance in 2...
Korean Authorities Raid Novartis Offices Over Bribery Al...
CPA: Review of Chinese Hospital Drug Market 2015
Data Snapshot - Drug Consumption of Level 2 and 3 General Hospi...
Data Snapshot: Chinese Insulin Market in 2015
IMS: Review of Chinese Retail Pharmacy OTC Drug Sales in 2015
IMS: New Market Trends in the Changing Chinese Retail Pharmacy ...
NT Pharma, Novartis Enter $145M Deal for China and Other Ter...
Value of Asia Pacific Healthcare Buyout Deals Peaked in 2015...
GE Healthcare Bullish over Long Term Prospects of Chinese Bi...
BGI and Clearbridge BioMedics to Co-develop China CTC Liquid...
PaizaBio, Ausia Bio to Contract Manufacture Biologic Injecta...
CFDA Issues Guidelines for Exemption of Human Bioequival...
CFDA Issues the Procedures for Reference Product Filing ...
Review of Class 1 New Drug Approvals between 2003 and 20...
CFDA Solicits Comments for Document on Linked Review and...
CFDA Announces Drug Approvals in April 2016
China Leads Global Pharma Innovation? By Number of Patent Ap...
USTR Singles Out China's Pharma IP Flaws in 2016 Special 301...
More Details Surface for the Recent GSK Trade Secret Theft C...
WIPO Says China's Innovation Capacity Improving As the Count...
Proposal for Pharmacist Legislation Ready for NPC Submission...
UK Regenerative Medicine Supplier Expands to China Thru ...
FDA Issues More Warnings Against Chinese API Producers
Dong-A ST Signs Exclusive Deal with Suzhou Sino for Teri...
French Inspectors Uncover Irregularities of Chinese Crud...
Zhejiang Jiuzhou Enters API Supply Agreement with Novart...
Eisai's Breast Cancer Drug Positive in China Phase III T...
CASI Pharma Approved by CFDA to Conduct ENMD-2076 Phase ...
Oramed Pharma Granted Chinese Patent for Oral Drug Deliv...
BeiGene Presents Positive Clinical Data for RAF Dimer In...
Chi-Med Begins Phase I Trial of HMPL-689 in Australia
New Study: China, India Face Huge Mental Health Challeng...
NHFPC Announces First Round Outcome of National Drug Pri...
State Council Announces Addition of Seven Provincial Lev...
NHFPC and MOF Announce Addition of 100 New Trial Site Ci...
Breast Cancer Cases Rise in China Despite Morbidity Fall...
Recent Executive Movements
Recent Executive Moves
Senior CFDA Official Fired for Disciplinary Violations
Recent Executive Moves
Recent Executive Moves
Upcoming Event: Pharma Business Development Course
NHFPC Vice Minister Meets Sanofi Pasteur President
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma China Seminar 2016 in NJ on April...
Upcoming Event: Pharma China Seminar 2016 in NJ on April...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links